S'abonner

Pathogen spectrum and antifungal susceptibility profile of ocular fungal infections in Northwest China from 2018 to 2023 - 19/11/26

Doi : 10.1016/j.mycmed.2026.101672 
Na Zhao a , Le Liang a, Mi Hao b , Chao Liu c, Xiaowei Zheng a, ⁎, 1 , Yan Cheng b, c, d, ⁎, 2
a Department of Pharmacy, First Affiliated Hospital of Northwest University, Xi’an No.1 Hospital, Xi’an, 710002, Shaanxi Province, China 
b Department of Ophthalmology, First Affiliated Hospital of Northwest University, Xi’an No.1 Hospital, Xi’an, 710002, Shaanxi Province, China 
c Shaanxi Institute of Ophthalmology, Xi’an, 710002, Shaanxi Province, China 
d Ophthalmic Disease Clinical Medical Research Center of Shaanxi, Xi’an, 710002, Shaanxi Province, China 

⁎ Corresponding author at: Department of Pharmacy, First Affiliated Hospital of Northwest University, Xi’an No. 1 Hospital, Xi’an, 710002, Shaanxi Province, China. Department of Pharmacy First Affiliated Hospital of Northwest University Xi’an No. 1 Hospital Xi’an Shaanxi Province 710002 China ⁎⁎ Corresponding author at: Department of Ophthalmology, Ophthalmic Disease Clinical Medical Research Center of Shaanxi, Shaanxi Institute of Ophthalmology, First Affiliated Hospital of Northwest University, Xi’an No. 1 Hospital, Xi’an, 710002, Shaanxi Province, China. Department of Ophthalmology Ophthalmic Disease Clinical Medical Research Center of Shaanxi Shaanxi Institute of Ophthalmology, First Affiliated Hospital of Northwest University Xi’an No. 1 Hospital Xi’an Shaanxi Province 710002 China

Research highlights

•
This retrospective study provides a comprehensive epidemiological analysis of ocular fungal infections in Northwest China, a region with limited published data in this field. Our study includes 652 culture-positive isolates from 592 patients over a six-year period (2018–2023).
•
The predominance of Fusarium spp. (62.7%), followed by Alternaria spp. (19.0%) and Aspergillus spp. (11.8%).
•
A significant increase in Alternaria spp. after 2020, surpassing Aspergillus spp. as the second most common pathogen.
•
Voriconazole demonstrated the highest in vitro susceptibility (94.0%); fluconazole remains effective against yeast infections.
•
Over 90% required invasive keratoplasty.

Le texte complet de cet article est disponible en PDF.

Abstract

Purpose

To analyze the pathogen spectrum, in vitro antifungal susceptibility profiles, and clinical management of culture-positive ocular fungal infections in Northwest China from 2018 to 2023.

Methods

A single-center retrospective observational study was conducted. Clinical and mycological data from patients with culture-confirmed ocular fungal infections were collected. Demographic characteristics, seasonal distribution, pathogen profiles, antifungal susceptibility, the trends of common pathogens in the cornea and anterior chamber, and clinical treatment records were analyzed.

Results

A total of 652 fungal isolates were obtained from 592 eligible patients, covering 29 distinct fungal species. Patients aged 41–60 years constituted the largest subgroup (312, 52.7%). Isolates collected from September to the following January accounted for 57.3% of all strains, overlapping with local agricultural harvest periods. The dominant pathogens were Fusarium spp. (409, 62.7%), Alternaria spp. (124, 19.0%), and Aspergillus spp. (77, 11.8%) in both the cornea and the anterior chamber. Notably, Alternaria spp prevalence increased significantly after 2020 and surpassed Aspergillus spp as the second common genus. Fusarium spp and Alternaria spp were significantly more frequent from corneal specimens than from the anterior chamber ( p  = 0.018; p  = 0.047, respectively), while the proportion of corneal Fusarium spp showed a declining trend ( p  = 0.044). Antifungal susceptibility testing demonstrated voriconazole possessed the highest overall susceptibility rate (94.0%), followed by natamycin (70.2%). All filamentous fungi exhibited high fluconazole resistance, whereas yeast isolates, including Candida albicans and Eumycota strains were fully susceptible to fluconazole. Among 590 patients with complete treatment records, only 6.44% received conservative management (medical monotherapy or amniotic membrane transplantation), while 93.56% required invasive surgical intervention, including penetrating keratoplasty (43.39%) and lamellar keratoplasty (35.76%). Fisher’s exact test revealed statistically significant overall differences in invasive surgery rates across five pathogen groups ( p  = 0.026); Fusarium spp ., yeast-like fungi, and Aspergillus spp . presented high surgical rates ( > 90%), whereas Alternaria spp . had the lowest surgical requirement (80.0%). Unadjusted 2 × 2 comparisons suggested crude associations between voriconazole/fluconazole susceptibility and surgical risk ( p  = 0.042, p  = 0.009). No significant crude association was observed for natamycin, terbinafine, or amphotericin B. After Bonferroni correction for multiple comparisons, only the crude association for fluconazole remained statistically significant.

Conclusions

Ocular fungal infections predominantly affect middle-aged and elderly male farmers in rural Northwest China, with peak incidence during autumn and winter crop harvests. Fusarium spp., Alternaria spp., and Aspergillus spp. are the major pathogens in both the cornea and the anterior chamber. Fusarium spp . remains the dominant pathogen, and elderly patients have a higher risk of Alternaria infection. Over 90% of patients develop severe corneal lesions requiring invasive surgery. Voriconazole exhibits broad-spectrum in vitro antifungal activity, which may inform empirical antifungal selection; fluconazole shows in vitro active against yeasts but lacks activity against filamentous fungi. Fungal genus is associated with the likelihood of surgical intervention. The crude association between fluconazole susceptibility and surgical risk is largely explained by the uneven distribution of yeast and filamentous fungal isolates. Preventive strategies targeting agricultural corneal trauma and early individualized antifungal therapy may help reduce severe surgical outcomes.

Le texte complet de cet article est disponible en PDF.

Keywords : Ocular fungal infections, Fungal keratitis, Epidemiology, Pathogens, Antifungal susceptibility


Plan


© 2026  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 37 - N° 1

Article 101672- mars 2027 Retour au numéro
Article précédent Article précédent
  • Overcoming hurdles in developing a reliable and reproducible biofilm model of Malassezia applied to M. furfur, M. pachydermatis, M. sympodialis and M. slooffiae
  • Jean-Etienne Porcheron, Louise Nalet, Stéphanie Crapart, Marion Girardot, Christine Imbert, Estelle Cateau
| Article suivant Article suivant
  • Artificial intelligence in dermatophytosis: Toward better clinical diagnosis and management
  • Wenjie Li, Weida Liu, Guanzhao Liang, Xiaofang Li

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2026 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.